AN2 Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
AN2 Therapeutics, Inc.
CIK #0001880438
EDGAR Form CIK 2011 - 2025
10-K [0001880438]
10-Q [0001880438]
3 [0001880438]
4 [0001880438]
8-K [0001880438]
SC 13D [0001880438]
SC 13G [0001880438]
Form 13D/13G Filer Form 13D/13G Subject Filed
Coastlands Capital Partners LP AN2 Therapeutics Inc [2025-06-04]
BML Investment Partners LP AN2 Therapeutics Inc [2025-05-07]
BML Investment Partners LP AN2 Therapeutics Inc [2024-08-12]
Octagon Capital Advisors LP AN2 Therapeutics Inc [2024-07-03]
Frazier Life Sciences Public Fund LP AN2 Therapeutics Inc [2024-04-10]
Easom Eric AN2 Therapeutics Inc [2024-02-13]
TCG Crossover GP I LLC AN2 Therapeutics Inc [2023-07-25]
Janus Henderson Group PLC AN2 Therapeutics Inc [2023-07-05]
Pfizer Inc AN2 Therapeutics Inc [2023-02-13]
BRII Biosciences Ltd AN2 Therapeutics Inc [2023-02-13]
View All
Form 3/4/5 Subject 2011 - 2025
Martin Patricia A.
AN2 Therapeutics, Inc.
Marks Gilbert Lynn
Aziz Kabeer
Leonard Braden Michael
Easom Eric
FitzPatrick Margaret M
Readnour Robin Shane
Zakrzewski Joseph S
Spigelman Melvin K
Wong Stephanie
Eizen Joshua M
Prior Stephen David
Chanda Sanjay
Day Lucy
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II, L.P.
Shah Rajeev M.
Krause Kevin Michael
Eckburg Paul
Adjuvant Global Health Technology Fund, L.P.
Adjuvant Global Health Technology Fund DE, L.P.
Adjuvant Capital GP, L.P.
Adjuvant Capital Management, LLC
Nazak Michael Adrian
Terms | Privacy | Guide
tony@aum13f.com